Cargando…
A high-throughput microfluidic approach for 1000-fold leukocyte reduction of platelet-rich plasma
Leukocyte reduction of donated blood products substantially reduces the risk of a number of transfusion-related complications. Current ‘leukoreduction’ filters operate by trapping leukocytes within specialized filtration material, while allowing desired blood components to pass through. However, the...
Autores principales: | Xia, Hui, Strachan, Briony C., Gifford, Sean C., Shevkoplyas, Sergey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075940/ https://www.ncbi.nlm.nih.gov/pubmed/27775049 http://dx.doi.org/10.1038/srep35943 |
Ejemplares similares
-
Author Correction: A high-throughput microfluidic approach for 1000-fold leukocyte reduction of platelet-rich plasma
por: Xia, Hui, et al.
Publicado: (2022) -
Leukocyte-Rich Platelet-Rich Plasma Has Better Stimulating Effects on Tenocyte Proliferation Compared With Leukocyte-Poor Platelet-Rich Plasma
por: Lin, Keng-Yi, et al.
Publicado: (2022) -
Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration
por: Xu, Zhengliang, et al.
Publicado: (2017) -
Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023) -
Platelet-Rich Plasma Centrifugation Changes Leukocyte Ratios
por: Harrison, Theodore E, et al.
Publicado: (2021)